Subscribe to Search results

Chris Harrington in a letter to Richard Gutowski asked whether there would be provision made for those who had cleared the virus in the proposed ex gratia payments scheme.

Published on:

Lord Ross proposed initial lump sum payments and a discretionary trust making ex gratia payments to all those who had probably received blood, blood products or tissue from the NHS in Scotland and who had become infected with Hepatitis C.

Published on:

Dr Paul Giangrande had been part of a working group which had produced a report about an appropriate payment scheme for the Haemophilia Society in June 2002.

Published on:

In "S and Others v the National Blood Authority" a 17-year-old boy cleared HCV and received compensation for an adjustment disorder. This evidence was used in the report for the HCV working party regarding compensation in order to argue in favour of a position for including natural clearers in the compensation scheme.

Published on:

The Haemophilia Society responded that a report published into HCV published by the Scottish Executive was a "very thin, incomplete piece of work which does not represent the full inquiry we were seeking".

Published on:

"The Guardian" reported that widows and children of people with haemophilia who had died from contaminated blood products could be excluded from a government aid package.

Published on:

The application form regarding the Skipton Fund was agreed by all four nations.

Published on:

An IBI counsel presentation on the Skipton Fund noted that the majority of Skipton applications were accepted. However, out of those applications that appealed after initial refusal, 49.5% of appeals were accepted.

Published on:

Records of Hepatitis B patients were frequently missing and there was no check back to see where the donation had come from.

Published on:

The Inquiry's interim report highlighted the importance of ensuring Hepatitis B sufferers had been supported in any compensation scheme that might occur.

Published on:

Compensation could not be given for those infected with Hepatitis C as a result of a donation that was given after 1 September 1991. No case would be reviewed that did not meet this cut off point.

Published on:

Long-lasting effects of Hepatitis C were not fully considered by the funds and compensation schemes as it was difficult to identify symptoms of the disease before it was formally diagnosed.

Published on:

John Dillon noted that according to the evidence of the Expert Group on Hepatitis, 20% of Hepatitis B infections would clear spontaneously.

Published on:

Unsuccessful applicants to the Skipton Fund were ignorant of the detail of reasoning that led to the rejection of their claims. Nicholas Fish noted that those who had asked for a copy of letters and reports relating to their decision would have been given one.

Published on:

Some applicants who admitted to intranasal or oral drug consumption, but not to injection, were denied on the basis of intravenous drug use, even though their medical records contained no reference to any such use.

Published on:

Mark Mildred was told by Nicholas Fish when he began working for the Skipton Panel and asked what sort of decision was wanted, to provide "A letter, keeping it as brief and simple as you can."

Published on:

Mark Mildred was not initially given, nor did he ask for, a copy of the Agency Agreement under which the Skipton Fund operated under the Department of Health.

Published on:

William Vineall stated in his evidence: "we think the testing regime that was established, I think in about 1972, for hepatitis B was sufficient to ensure that people with hepatitis B wouldn't be, you know, subject to the risk of infected blood, and that's why it's never been part of any scheme".

Published on:

Dame Marcela Contreras advised that where GP records for the time were available, they may have included discharge letters which may have referred to transfusions, but equally may not.

Published on:

Dr Patricia Hewitt suggested that though records should have been made to show that a transfusion had been given, and identifying numbers of the transfused units recorded, practice about this was often casual, and records were often not retained for the length of time necessary to help show some years later that a transfusion had taken place.

Published on: